Hemispherx Biopharma buy melinda
Start price
18.08.10
/
50%
€231.79
Target price
18.02.11
€462.00
Performance (%)
-20.05%
End price
18.02.11
€185.33
Summary
This prediction ended on 18.02.11 with a price of €185.33. The prediction for Hemispherx Biopharma disappointed with a performance of -20.05%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Hemispherx Biopharma | - | - | - | - |
iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by melinda for this prediction
In the thread Hemispherx Biopharma diskutieren
Biopharma-
hemispherix Biopharma verkündete seine Schlacht gewonnen sechs Jahren südafrikanischen Investoren, dass sie gewonnen haben
(Laufzeit überschritten)
Stopped prediction by melinda for Hemispherx Biopharma
Hemispherx Biopharma
Start price
Target price
Perf. (%)
€20.02
18.05.17
18.05.17
€26.40
26.05.17
26.05.17
5.27%
26.05.17
26.05.17